RNAi inhibition of serum amyloid A for treatment of glaucoma

Details for Australian Patent Application No. 2005322228 (hide)

Owner Alcon, Inc.

Inventors McNatt, Loretta; Clark, Abbot F.; Wang, Wan-Heng

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005322228

PCT Pub. Number WO2006/071691

Priority 60/638,706 23.12.04 US

Filing date 19 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 11 August 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/071691 Priority application(s): WO2006/071691

11 August 2011 Application Accepted

  Published as AU-B-2005322228

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322231-Visco-supplement composition and methods

2005322227-Force sensing membrane